237 related articles for article (PubMed ID: 31161747)
1. Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs.
Hwang JH; Lee KN; Kim SM; Lee G; Moon Y; Kim B; Lee JS; Park JH
J Vet Sci; 2019 May; 20(3):e29. PubMed ID: 31161747
[TBL] [Abstract][Full Text] [Related]
2. Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs.
Choi JH; You SH; Ko MK; Jo HE; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Lee JS; Park JH
J Vet Sci; 2020 Sep; 21(5):e74. PubMed ID: 33016020
[TBL] [Abstract][Full Text] [Related]
3. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
[TBL] [Abstract][Full Text] [Related]
4. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
[TBL] [Abstract][Full Text] [Related]
5. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
[TBL] [Abstract][Full Text] [Related]
6. Intradermal vaccination of pigs against FMD with 1/10 dose results in comparable vaccine efficacy as intramuscular vaccination with a full dose.
Eblé PL; Weerdmeester K; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2009 Feb; 27(8):1272-8. PubMed ID: 19114077
[TBL] [Abstract][Full Text] [Related]
7. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
Mouton L; Dekker A; Bleijenberg M; Blanchet M; Coco-Martin J; Hudelet P; Goutebroze S
Vaccine; 2018 Apr; 36(15):2020-2024. PubMed ID: 29510916
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of different adjuvants for foot-and-mouth disease vaccine containing all the SAT serotypes.
Cloete M; Dungu B; Van Staden LI; Ismail-Cassim N; Vosloo W
Onderstepoort J Vet Res; 2008 Mar; 75(1):17-31. PubMed ID: 18575060
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
[TBL] [Abstract][Full Text] [Related]
10. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
11. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge.
Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS
Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
[TBL] [Abstract][Full Text] [Related]
13. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
14. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V
Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
[TBL] [Abstract][Full Text] [Related]
16. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
[TBL] [Abstract][Full Text] [Related]
17. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
[TBL] [Abstract][Full Text] [Related]
18. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
[TBL] [Abstract][Full Text] [Related]
19. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge.
Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM
Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957
[TBL] [Abstract][Full Text] [Related]
20. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]